Deshauer Dorian, Duffy Anne, Meaney Michael, Sharma Shakti, Grof Paul
Department of Psychiatry, University of Ottawa, Ottawa, Ontario, Canada.
Bipolar Disord. 2006 Aug;8(4):345-9. doi: 10.1111/j.1399-5618.2006.00338.x.
It is generally believed that cortisol secretion normalizes during clinical remission in mood disorders. However, this assumption has been challenged by preliminary reports of enhanced cortisol secretion in remitted bipolar patients and in the offspring of bipolar parents. The purpose of this study is to replicate findings of increased cortisol secretion during clinical remission in bipolar patients and in the offspring of bipolar parents, rigorously controlling for known confounders.
We conducted intensive cortisol sampling (six samples per day for three test days, on three consecutive weekends) on 15 bipolar type I and type II patients and 28 unrelated offspring of bipolar parents. Offspring had a history of unipolar depression. Participation was restricted to cases in complete sustained remission. Controls were matched as closely as possible for age, sex, and education. Mood and sleep measures were recorded on each sampling day.
In total, 743 samples were collected from the patient group and 576 from controls. Correcting for repeat measures, there was no statistically significant difference in cortisol secretion at any sampling time between remitted bipolar patients, remitted offspring of bipolar parents, and normal controls. The cortisol waking response did not differ between patients and controls. Covariates, including sex, age, Beck depression score and hours of sleep, were not statistically significant.
Our observations are consistent with the view that complete sustained clinical remission is associated with normal salivary cortisol levels throughout the day. A personal or family history of bipolar disorder per se does not appear to confer added risk for increased salivary cortisol secretion during sustained clinical remission.
人们普遍认为,情绪障碍临床缓解期皮质醇分泌会恢复正常。然而,双相情感障碍缓解期患者及双相情感障碍患者后代皮质醇分泌增加的初步报告对这一假设提出了挑战。本研究的目的是在严格控制已知混杂因素的情况下,重复双相情感障碍患者及双相情感障碍患者后代临床缓解期皮质醇分泌增加的研究结果。
我们对15例Ⅰ型和Ⅱ型双相情感障碍患者以及28例双相情感障碍患者的非亲属后代进行了密集的皮质醇采样(连续三个周末,每个测试日每天采集六个样本)。后代有单相抑郁病史。研究对象仅限于完全持续缓解的病例。对照组在年龄、性别和教育程度方面尽可能进行匹配。在每个采样日记录情绪和睡眠指标。
患者组共采集了743个样本,对照组采集了576个样本。校正重复测量后,双相情感障碍缓解期患者、双相情感障碍患者后代缓解期及正常对照组在任何采样时间的皮质醇分泌均无统计学显著差异。患者和对照组的皮质醇觉醒反应无差异。包括性别、年龄、贝克抑郁评分和睡眠时间在内的协变量无统计学显著性。
我们的观察结果支持这样一种观点,即完全持续的临床缓解与全天唾液皮质醇水平正常有关。双相情感障碍的个人或家族史本身似乎并不会增加持续临床缓解期唾液皮质醇分泌增加的风险。